HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preconditioning of stem cells by oxytocin to improve their therapeutic potential.

Abstract
Principal limitation of cell therapy is cell loss after transplantation because of the interplay between ischemia, inflammation, and apoptosis. We investigated the mechanism of preconditioning of mesenchymal stem cells (MSCs) with oxytocin (OT), which has been proposed as a novel strategy for enhancing therapeutic potential of these cells in ischemic heart. In this study, we demonstrate that rat MSCs express binding sites for OT receptor and OT receptor transcript and protein as detected by RT-PCR and immunofluorescence, respectively. In response to OT (10(-10) to 10(-6) M) treatment, MSCs respond with rapid calcium mobilization and up-regulation of the protective protein kinase B (PKB or Akt) and phospho-ERK1/2 proteins. In OT-stimulated cells, phospho-Akt accumulates intracellularly close to the mitochondrial marker cytochrome c oxidase subunit 4. Functional analyses reveal the involvement of Akt/ERK1/2 pathways in cell proliferation, migration, and protection against the cytotoxic and apoptotic effects of hypoxia and serum deprivation. In addition, OT preconditioning increases MSC glucose uptake. Genes with angiogenic, antiapoptotic, and cardiac antiremodeling properties, such as heat shock proteins (hsps) HSP27, HSP32, HSP70, vascular endothelial growth factor, thrombospondin, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, TIMP-3, and matrix metalloproteinase-2, were also up-regulated upon OT exposure. Moreover, coculture with OT-preconditioned MSC reduces apoptosis, as measured using terminal transferase dUTP nick end labeling assay in newborn rat cardiomyocytes exposed to hypoxia and reoxygenation. In conclusion, these results indicate that OT treatment evokes MSC protection through both intrinsic pathways and secretion of cytoprotective factors. Ex vivo cellular treatment with OT represents an attractive strategy aimed to maximize the biological and functional properties of effector cells.
AuthorsNicolas Noiseux, Mélanie Borie, Alexandra Desnoyers, Ahmed Menaouar, Louis Mathieu Stevens, Samer Mansour, Bogdan A Danalache, Denis-Claude Roy, Marek Jankowski, Jolanta Gutkowska
JournalEndocrinology (Endocrinology) Vol. 153 Issue 11 Pg. 5361-72 (Nov 2012) ISSN: 1945-7170 [Electronic] United States
PMID23024264 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Oxytocin
  • Oxytocin
  • Electron Transport Complex IV
  • Proto-Oncogene Proteins c-akt
  • Calcium
Topics
  • Animals
  • Apoptosis (drug effects, physiology)
  • Calcium (metabolism)
  • Cell Hypoxia (drug effects)
  • Cell Movement (drug effects, physiology)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Electron Transport Complex IV (metabolism)
  • Mesenchymal Stem Cells (drug effects, metabolism)
  • Oxytocin (pharmacology)
  • Phosphorylation (drug effects)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Rats
  • Receptors, Oxytocin (genetics, metabolism)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: